EDNRA and pulmonary arterial hypertension: Moreover, a study from Becker et al. showed that the agonistic endothelin-1 type A receptor antibodies (anti-ETAR) are more common in SSc-PAH/ARDs-PAH than in other forms of PAH and may predict prognosis in SSc-PAH [85].